Literature DB >> 7363532

Absorption of ocular timolol.

G Alvan, B Calissendorff, P Seideman, K Widmark, G Widmark.   

Abstract

The absorption of timolol after topical administration to the eye was studied in 11 healthy volunteers and in 5 patients with bilateral open angle glaucoma. The volunteers received 2 drops of 0.5% timolol ophthalmic solution in each eye, equivalent to 0.8 mg of timolol maleate. Overflow was absorbed by paper tissue. The patients received the same dose twice daily for 2 weeks and were then investigated. In the paper tissue, 12 to 88% of the dose administered was recovered. Plasma concentrations were never above 5 ng/ml and not always detectable (detection limit 1 to 2 ng/ml). However, timolol was absorbed as the drug was found in the urine samples from all volunteers and glaucomatous patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363532     DOI: 10.2165/00003088-198005010-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  16 in total

1.  beta-adrenoceptor antagonism and intraocular pressure. A clinical study on propranolol, practolol and atenolol.

Authors:  K Wettrell
Journal:  Acta Ophthalmol Suppl       Date:  1977

2.  Timolol and facility of outflow.

Authors:  T J Zimmerman; R Harbin; M Pett; H E Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-07       Impact factor: 4.799

3.  Exacerbation of asthma by timolol.

Authors:  F L Jones; N L Ekberg
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

4.  Topical propranolol and ocular tension in the human.

Authors:  J Vale; A C Gibbs; C I Phillips
Journal:  Br J Ophthalmol       Date:  1972-10       Impact factor: 4.638

5.  Effect of pindolol on intraocular pressure.

Authors:  I Bonomi; P Steindler
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

6.  Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.

Authors:  T F Patton; M Francoeur
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

7.  Plasma timolol levels after oral and intravenous administration.

Authors:  O F Else; H Sorenson; I R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

8.  Electron-capture GLC determination of timolol in human plasma and urine.

Authors:  D J Tocco; F A deLuna; A E Duncan
Journal:  J Pharm Sci       Date:  1975-11       Impact factor: 3.534

9.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

10.  Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.

Authors:  W P Boger; C A Puliafito; R F Steinert; D P Langston
Journal:  Ophthalmology       Date:  1978-03       Impact factor: 12.079

View more
  20 in total

Review 1.  Medical treatment of glaucoma--a reappraisal of the risks.

Authors:  P Diggory; W Franks
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

Review 2.  Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.

Authors:  Nevio Cimolai
Journal:  Clin Med Res       Date:  2019-08-28

Review 3.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 4.  Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.

Authors:  J A Balfour; M I Wilde
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

5.  Sublingual timolol--an alternative to topical medication in glaucoma?

Authors:  S A Sadiq; S A Vernon
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

6.  Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.

Authors:  K G Bauer; F Brunner-Ferber; L M Distlerath; E A Lippa; B Binkowitz; P Till; G A Kaik
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

7.  Concentration of timolol in aqueous humour.

Authors:  L J Blanksma
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

Review 8.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

9.  Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol.

Authors:  M Nakashima; T Uematsu; Y Takiguchi; H Hashimoto; I Watanabe; S Morioka; T Hibino
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Changes in depressive status associated with topical beta-blockers.

Authors:  S Duch; C Duch; L Pastó; P Ferrer
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.